Show items per page
Elements: 4
Page 1 on 1
 TitleAuthors / EditorsDate
add to browser selection
EULAR points to consider when establishing, analysing and reporting safety data of biologics registers in rheumatology Dixon, William G.; Carmona, Loreto; Finckh, Axel; Hetland, Merete Lund; ... Askling, Johan 2010
add to browser selection
Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries Chatzidionysiou, Katerina; Lie, Elisabeth; Nasonov, Evgeny; Lukina, Galina; ... van Vollenhoven, Ronald F 2011
add to browser selection
Effectiveness of disease-modifying antirheumatic drug co-therapy with methotrexate and leflunomide in rituximab-treated rheumatoid arthritis patients: results of a 1-year follow-up study from the CERERRA collaboration Chatzidionysiou, Katerina; Lie, Elisabeth; Nasonov, Evgeny; Lukina, Galina; ... Gabay, Cem 2012
add to browser selection
Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration Chatzidionysiou, Katerina; Lie, Elisabeth; Nasonov, Evgeny; Lukina, Galina; ... van Vollenhoven, Ronald F 2016